All Articles

Browse all articles — filter by topic, how strong the science is, or date.

Showing 385–408 of 416 in Industry & Access

Mar 16, 2026investor.lilly.com

Lilly's EBGLYSS (lebrikizumab-lbkz) is the first and only selective IL-13 inhibitor to deliver positive Phase 3 outcomes in patients aged six months to 18 years with moderate-to-severe atopic dermatitis

landmarkIndustry & Access

Mar 16, 2026investor.lilly.com

Lilly's EBGLYSS (lebrikizumab-lbkz) is the first and only selective IL-13 inhibitor to deliver positive Phase 3 outcomes in patients aged six months to 18 years with moderate-to-severe atopic dermatitis

landmarkIndustry & Access

Mar 16, 2026labiotech.eu

13 anti-aging biotech companies to watch in 2026 - Labiotech.eu

significantIndustry & Access

Mar 14, 2026news.google.com

Experts say this activity rebuilds mitochondria and may slow aging - Fast Company

generalIndustry & Access

Mar 14, 2026longevity.technology

MBX Biosciences reports 2025 results and advances endocrine pipeline

landmarkIndustry & Access

Mar 14, 2026longevity.technology

Aspen wins official name for Parkinson’s cell therapy candidate

generalIndustry & Access

Mar 14, 2026longevity.technology

Cymbiotika partners with Ulta Beauty for nationwide retail rollout

generalIndustry & Access

Mar 13, 2026longevity.technology

Theriva Biologics reports 2025 results and pipeline progress

landmarkIndustry & Access

Mar 12, 2026lifespan.io

Xplore Program 2026: A Remote Summer Fellowship in Longevity

significantIndustry & Access

Mar 12, 2026investor.lilly.com

An open letter from Eli Lilly and Company warning of potential patient safety risks associated with tirzepatide compounded with vitamin B12

significantIndustry & Access

Mar 12, 2026investor.lilly.com

An open letter from Eli Lilly and Company warning of potential patient safety risks associated with tirzepatide compounded with vitamin B12

significantIndustry & Access

Mar 6, 2026labiotech.eu

13 anti-aging biotech companies to watch in 2026 - Labiotech.eu

generalIndustry & Access

Mar 2, 2026news.google.com

Pharmas and biotechs are investing in new treatments for diseases of aging - Clarivate

generalIndustry & Access

Feb 27, 2026academic.oup.com

Weighted vest use or resistance exercise to offset muscle loss in older adults: secondary findings from the INVEST in bone health RCT

significantIndustry & Access

Feb 27, 2026academic.oup.com

Weighted vest use or resistance exercise to offset muscle loss in older adults: secondary findings from the INVEST in bone health RCT

significantIndustry & Access

Feb 27, 2026academic.oup.com

Weighted vest use or resistance exercise to offset muscle loss in older adults: secondary findings from the INVEST in bone health RCT

significantIndustry & Access

Feb 25, 2026fiercebiotech.com

ARPA-H designates up to $144M for anti-aging medical research - Fierce Biotech

landmarkIndustry & Access

Feb 24, 2026news.google.com

News | Signs of life: Longevity startup to be first tenant for San Francisco biotech project - CoStar

generalIndustry & Access

Feb 20, 2026biospace.com

Organic Longevity Biotechnology: A New Paradigm for Anti-Aging, Lifespan Extension, and Rejuvenation - BioSpace

landmarkIndustry & Access

Feb 20, 2026biospace.com

Organic Longevity Biotechnology: A New Paradigm for Anti-Aging, Lifespan Extension, and Rejuvenation - BioSpace

significantIndustry & Access

Jan 30, 2026fortune.com

This startup has the lead in longevity, securing the first FDA-approved partial de-aging human trial - Fortune

significantIndustry & Access

Jan 30, 2026technologyreview.com

How the sometimes-weird world of lifespan extension is gaining influence - MIT Technology Review

generalIndustry & Access

Jan 27, 2026endpoints.news

Exclusive: In major test for longevity field, FDA greenlights study on a 'near total reset' of cells - Endpoints News

landmarkIndustry & Access

Jan 24, 2026immunitybio.com

USA–Saudi Biotech Alliance Summit Marks a New Era in Healthspan, Immunotherapy, and Global Scientific Partnership - ImmunityBio

significantIndustry & Access